These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 7067077)
1. New type of acute porphyria with porphobilinogen synthase (delta-aminolevulinic acid dehydratase) defect in the homozygous state. Doss M; Schneider J; Von Tiepermann R; Brandt A Clin Biochem; 1982 Feb; 15(1):52-5. PubMed ID: 7067077 [TBL] [Abstract][Full Text] [Related]
2. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation. Doss M; von Tiepermann R; Schneider J; Schmid H Klin Wochenschr; 1979 Oct; 57(20):1123-7. PubMed ID: 513604 [TBL] [Abstract][Full Text] [Related]
3. Porphobilinogen-synthase (delta-aminolevulinic acid dehydratase) deficiency in bone marrow cells of two patients with porphobilinogen-synthase defect acute porphyria. Doss M; Tiepermann RV; Schneider J Klin Wochenschr; 1983 Jul; 61(14):699-702. PubMed ID: 6887758 [TBL] [Abstract][Full Text] [Related]
4. Hereditary prophobilinogen synthase deficiency in human associated with acute hepatic porphyria. Brandt A; Doss M Hum Genet; 1981; 58(2):194-7. PubMed ID: 7287003 [TBL] [Abstract][Full Text] [Related]
5. Hereditary hepatic porphyria due to homozygous delta-aminolevulinic acid dehydratase deficiency: studies in lymphocytes and erythrocytes. Sassa S; Fujita H; Doss M; Hassoun A; Verstraeten L; Mercelis R; Kappas A Eur J Clin Invest; 1991 Apr; 21(2):244-8. PubMed ID: 1905639 [TBL] [Abstract][Full Text] [Related]
6. Persistent protoporphyrinemia in hereditary porphobilinogen synthase (delta-aminolevulinic acid dehydrase) deficiency under low lead exposure. A new molecular basis for the pathogenesis of lead intoxication. Doss M; Becker U; Sixel F; Geisse S; Solcher H; Schneider J; Kufner G; Schlegel H; Stoeppler M Klin Wochenschr; 1982 Jun; 60(12):599-606. PubMed ID: 7109500 [TBL] [Abstract][Full Text] [Related]
7. The third case of Doss porphyria (delta-amino-levulinic acid dehydratase deficiency) in Germany. Doss MO; Stauch T; Gross U; Renz M; Akagi R; Doss-Frank M; Seelig HP; Sassa S J Inherit Metab Dis; 2004; 27(4):529-36. PubMed ID: 15303011 [TBL] [Abstract][Full Text] [Related]
8. Acute hepatic porphyria syndrome with porphobilinogen synthase defect. Doss M; von Tiepermann R; Schneider J Int J Biochem; 1980; 12(5-6):823-6. PubMed ID: 7450139 [No Abstract] [Full Text] [Related]
17. Studies in porphyria. V. Drug oxidation rates in hereditary hepatic porphyria. Anderson KE; Alvares AP; Sassa S; Kappas A Clin Pharmacol Ther; 1976 Jan; 19(1):47-54. PubMed ID: 1245093 [TBL] [Abstract][Full Text] [Related]
18. The porphyrias: recent advances. Hindmarsh JT Clin Chem; 1986 Jul; 32(7):1255-63. PubMed ID: 3521939 [TBL] [Abstract][Full Text] [Related]
19. Normal erythrocyte uroporphyrinogen I synthase in a kindred with acute intermittent porphyria. Mustajoki P Ann Intern Med; 1981 Aug; 95(2):162-6. PubMed ID: 7258864 [TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of porphyrins, porphobilinogen and δ-aminolaevulinic acid following an attack of acute intermittent porphyria. Marsden JT; Rees DC J Clin Pathol; 2014 Jan; 67(1):60-5. PubMed ID: 23908454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]